Why Weight Loss Plateaus Happen & Your Medication Options
Why Am I Not Losing Weight on Wegovy? Understanding Medication Differences
When patients ask "why am I not losing weight on Wegovy?", the answer often lies in individual medication response rather than treatment failure. Wegovy (semaglutide) works as a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors—a dual mechanism that may provide different results for some patients. Clinical experience suggests that approximately 10-15% of patients respond better to one medication over the other, which is why having access to both options through EverydayMeds can be crucial for your weight management success. Your prescriber can evaluate your current Wegovy response and determine whether switching to Mounjaro's dual-hormone approach might be more suitable for your metabolism.
The timing of this question "why am I not losing weight on Wegovy?" is equally important to consider. Weight loss typically occurs in phases, with initial rapid results followed by stabilisation periods around weeks 12-16. If you're experiencing a plateau on your current Wegovy dose, this could indicate the need for dose escalation to the full 2.4mg maintenance level, or alternatively, a trial of Mounjaro's different mechanism. Both medications require the full dose escalation protocol and must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Wegovy vs Mounjaro Pricing: Complete UK Cost Comparison
Understanding the investment required for each medication helps answer "why am I not losing weight on Wegovy?" from a practical perspective. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg) to £209.99 for the 2.4mg maintenance dose. Mounjaro follows a similar escalation pattern with different dosing intervals. New customers benefit from code FIRST40 applied at checkout, whilst returning customers use DOSE25 to reach these final prices. Our Getting Started bundles like the Intro Duo (£169.99) provide both starter doses in one convenient order, reducing the complexity of managing your treatment transition.
For patients questioning "why am I not losing weight on Wegovy?" and considering a switch, our flexible ordering system allows seamless transition between medications. Both treatments are prescription-only medicines requiring clinical assessment, but EverydayMeds' streamlined process means you can explore Mounjaro without changing pharmacy or starting complex new registrations. The Consistency bundles offer two months of the same dose (e.g., Consistency 2.4mg for £419.99), providing stability once you've found your optimal treatment, whether that's Wegovy or Mounjaro.
Clinical Evidence: Why Am I Not Losing Weight on Wegovy Compared to Mounjaro?
Research helps explain why some patients ask "why am I not losing weight on Wegovy?" when comparing treatment options. In the STEP trials, patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 3 trial demonstrated approximately clinically studied weight loss when combined with intensive behavioural therapy. However, individual responses vary significantly, which is why some patients may find Mounjaro's dual GIP/GLP-1 mechanism more suitable for their physiology.
The STEP 5 long-term data showed sustained weight loss of approximately 15.2% at 2 years, whilst the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. These results represent population averages, and patients asking "why am I not losing weight on Wegovy?" should understand that 10-20% of people may be better suited to alternative treatments like Mounjaro, which targets additional hormone pathways for appetite and glucose regulation.
How Wegovy Works: Understanding Your Current Treatment Mechanism
To understand "why am I not losing weight on Wegovy?", it's essential to grasp how semaglutide functions in your body. Wegovy is a GLP-1 receptor agonist that mimics a natural fullness hormone, working primarily in your brain's appetite centres to reduce food cravings and promote satiety after smaller meals. This mechanism slows gastric emptying, meaning food stays in your stomach longer, creating sustained feelings of fullness. The medication also influences insulin sensitivity and glucose metabolism, though these are secondary effects compared to its primary appetite-regulating action. Some patients may find that their GLP-1 receptors become less responsive over time, or their individual physiology may respond better to Mounjaro's additional GIP receptor activation, which affects different metabolic pathways including fat storage and energy expenditure.
Starting Your Assessment: From Question to Prescription
If you're asking "why am I not losing weight on Wegovy?" and want to explore Mounjaro as an alternative, EverydayMeds makes the transition straightforward through our comprehensive process. Begin with our 3-minute online clinical assessment, where you can detail your current Wegovy experience and weight loss goals. Our UK-qualified prescribers (GPhC #9012878) review your submission within 3 working days (or 24 hours with express service) and can recommend whether continuing Wegovy with dose adjustment or switching to Mounjaro would be more appropriate. Once approved, your chosen prescription-only medicine is dispatched via next-day cold-chain delivery, maintaining the strict temperature requirements both medications need. This seamless process means you can address "why am I not losing weight on Wegovy?" with expert medical guidance rather than guessing about treatment changes.
Storage and Practical Differences Between Wegovy and Mounjaro
Practical considerations often influence the "why am I not losing weight on Wegovy?" decision when comparing with Mounjaro. Both medications require refrigerator storage at 2-8°C before first use, but Wegovy offers superior travel convenience with 6 weeks of room temperature stability (below 30°C) compared to Mounjaro's 21-day limit. The FlexTouch pen delivery system for Wegovy is designed for once-weekly injection, with dose escalation from 0.25mg through to 2.4mg maintenance over 16 weeks—this gradual increase minimises side effects whilst maximising efficacy. Mounjaro uses a similar escalation protocol but with different dose increments (2.5mg up to 15mg), and some patients find the injection experience varies between the two pen designs. Both are prescription-only medicines requiring proper disposal of used pens and adherence to the structured dose escalation schedule your prescriber will outline.
Plateau Management: Why Am I Not Losing Weight on Wegovy After Initial Success?
Many patients asking "why am I not losing weight on Wegovy?" are actually experiencing normal treatment plateaus rather than medication failure. Weight loss typically occurs in phases: rapid initial loss (weeks 1-8), steady progression (weeks 8-16), and maintenance stabilisation (week 17 onwards). If you've stalled on a lower Wegovy dose, progressing to the full 2.4mg maintenance level often restores momentum, as clinical trials show the highest efficacy at maximum dosing. Some patients require extended time at intermediate doses, whilst others benefit from the alternative mechanism that Mounjaro provides through its dual GLP-1/GIP action.
The question "why am I not losing weight on Wegovy?" becomes more significant if you've been stable on 2.4mg for 8-12 weeks without progress, have experienced significant side effects limiting dose escalation, or have underlying insulin resistance that might respond better to Mounjaro's GIP receptor effects. EverydayMeds' prescribers can evaluate your specific situation and recommend whether treatment optimisation, medication switching, or additional support strategies would be most beneficial for breaking through your current plateau.
Making Your Choice: Expert Support for Treatment Decisions
Rather than continuing to wonder "why am I not losing weight on Wegovy?", take action with EverydayMeds' comprehensive support for both treatment options. Use discount code FIRST40 for new customers or DOSE25 for returning patients—these codes are applied at checkout to reach our transparent pricing structure. Our clinical team (GPhC #9012878) provides ongoing support throughout your journey, whether that involves optimising your current Wegovy treatment or transitioning to Mounjaro's dual-hormone approach. Both medications are prescription-only medicines that require professional oversight, and our streamlined assessment process ensures you receive expert guidance tailored to your individual response patterns. Start your assessment today at our weight loss collection, where both Wegovy and Mounjaro are available with next-day delivery once your prescription is approved.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
